Kritische 8-K Meldungen
HOCH Abgang Schlüsselpersonen (25.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 25.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 07.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | tion 13(a) of the Exchange Act. ☒ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; A |
| 03.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | t 3, 2023, is attached as Exhibit 16.1 hereto. Item 5.02 Departure of Directors or Certain Officers; Election of Direc |
Stammdaten
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. The company was incorporated in 2014 and is headquartered in San Diego, California.
Unternehmen & Branche
| Name | Dermata Therapeutics, Inc. |
|---|---|
| Ticker | DRMA |
| CIK | 0001853816 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 824.684 USD |
| Beta | 0,50 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -7,558,557 | -8.16 | 7,863,826 | 6,223,380 | |
| 2025-09-30 | 10-Q | -1,691,989 | -1.65 | 5,071,410 | 3,960,102 | |
| 2025-06-30 | 10-Q | -1,701,093 | -1.66 | 6,640,516 | 5,614,251 | |
| 2025-03-31 | 10-Q | -2,303,587 | -0.45 | 10,005,007 | 7,301,222 | |
| 2024-12-31 | 10-K | -12,287,461 | -80.32 | 3,533,888 | 1,561,094 | |
| 2024-09-30 | 10-Q | -3,173,156 | -20.41 | 6,687,344 | 4,741,228 | |
| 2024-06-30 | 10-Q | -2,829,106 | -41.82 | 5,236,552 | 3,318,127 | |
| 2024-03-31 | 10-Q | -3,134,262 | -7.06 | 5,179,756 | 3,807,990 | |
| 2023-12-31 | 10-K | -7,794,690 | -39.99 | 7,978,634 | 6,355,018 | |
| 2023-09-30 | 10-Q | -1,719,211 | 7,323,383 | 6,406,566 | ||
| 2023-06-30 | 10-Q | -1,701,364 | 8,712,881 | 8,030,019 | ||
| 2023-03-31 | 10-Q | -2,240,142 | 9,295,105 | 8,088,070 | ||
| 2022-12-31 | 10-K | -9,610,913 | 6,944,488 | 6,021,854 | ||
| 2022-12-31 | 10-Q | -2,786,152 | 6,944,488 | 6,021,854 | ||
| 2022-09-30 | 10-Q | -2,424,586 | 8,974,889 | 7,470,567 | ||
| 2022-06-30 | 10-Q | -2,730,573 | 11,026,438 | 9,659,970 | ||
| 2022-03-31 | 10-Q | -2,786,151 | 9,044,015 | 7,852,519 | ||
| 2021-12-31 | 10-K | -7,902,477 | 11,623,940 | 10,107,104 | ||
| 2021-09-30 | 10-Q | -1,712,920 | 13,685,787 | 12,490,555 | ||
| 2021-06-30 | 10-Q | -1,331,792 | 1,136,864 | -505,802 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.